Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence.

Khambholja, Kapil; Asudani, Deepak

Khambholja, Kapil; Asudani, Deepak.

Affiliation

Khambholja K; Genpro Research Pvt Ltd, Technopark Campus, Thiruvananthapuram, Kerala, 695581, India. Electronic address: Kapil.khambholja@genproresearch.com.
Asudani D; Department of Medicine, Division of Hospital Medicine, University of California, San Diego, 92103, USA. Electronic address: dgasudani@health.ucsd.edu.

Travel Med Infect Dis ; 35: 101710, 2020.

Article in En | MEDLINE | ID: mdl-32360327

Subject(s)

Betacoronavirus; Coronavirus Infections; Pandemics; Pneumonia, Viral; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Amides; COVID-19; Coronavirus Infections/drug therapy; Humans; Pyrazines; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: En Journal: Travel Med Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google